BACKGROUND: Recent reports have linked variability in visit-to-visit systolic blood pressure (SBP) to risk of mortality and stroke, independent of the effect of mean SBP level. This study aimed to evaluate whether variability in SBP is associated with all-cause mortality, incident myocardial infarction (MI), and incident stroke, independent of mean SBP or trends in SBP levels over time. METHODS: The Cardiovascular Health Study is a longitudinal cohort study of vascular risk factors and disease in the elderly. Participants who attended their first 5 annual clinic visits and experienced no event before the 5th visit were eligible (n = 3,852). Primary analyses were restricted to participants not using antihypertensive medications throughout the first 5 clinic visits (n = 1,642). Intraindividual SBP variables were defined using each participant's 5-visit blood pressure measures. Cox proportional hazards models estimated adjusted hazard ratios (HRs) per SD increase in intraindividual SBP variability, adjusted for intraindividual SBP mean and change over time. RESULTS: Over a mean follow-up of 9.9 years, there were 844 deaths, 203 MIs, and 195 strokes. Intraindividual SBP variability was significantly associated with increased risk of mortality (HR = 1.13; 95% confidence interval (CI) = 1.05-1.21) and of incident MI (HR = 1.20; 95%CI = 1.06-1.36), independent of the effect from adjustment factors. Intraindividual SBP variability was not associated with risk of stroke (HR = 1.03; 95% CI = 0.89-1.21). CONCLUSIONS: Long-term visit-to-visit SBP variability was independently associated with a higher risk of subsequent mortality and MI but not stroke. More research is needed to determine the relationship of BP variability with cardiovascular risk and the clinical implications.
BACKGROUND: Recent reports have linked variability in visit-to-visit systolic blood pressure (SBP) to risk of mortality and stroke, independent of the effect of mean SBP level. This study aimed to evaluate whether variability in SBP is associated with all-cause mortality, incident myocardial infarction (MI), and incident stroke, independent of mean SBP or trends in SBP levels over time. METHODS: The Cardiovascular Health Study is a longitudinal cohort study of vascular risk factors and disease in the elderly. Participants who attended their first 5 annual clinic visits and experienced no event before the 5th visit were eligible (n = 3,852). Primary analyses were restricted to participants not using antihypertensive medications throughout the first 5 clinic visits (n = 1,642). Intraindividual SBP variables were defined using each participant's 5-visit blood pressure measures. Cox proportional hazards models estimated adjusted hazard ratios (HRs) per SD increase in intraindividual SBP variability, adjusted for intraindividual SBP mean and change over time. RESULTS: Over a mean follow-up of 9.9 years, there were 844 deaths, 203 MIs, and 195 strokes. Intraindividual SBP variability was significantly associated with increased risk of mortality (HR = 1.13; 95% confidence interval (CI) = 1.05-1.21) and of incident MI (HR = 1.20; 95%CI = 1.06-1.36), independent of the effect from adjustment factors. Intraindividual SBP variability was not associated with risk of stroke (HR = 1.03; 95% CI = 0.89-1.21). CONCLUSIONS: Long-term visit-to-visit SBP variability was independently associated with a higher risk of subsequent mortality and MI but not stroke. More research is needed to determine the relationship of BP variability with cardiovascular risk and the clinical implications.
Authors: L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman Journal: Ann Epidemiol Date: 1991-02 Impact factor: 3.797
Authors: Y Hata; Y Kimura; H Muratani; K Fukiyama; Y Kawano; T Ashida; M Yokouchi; Y Imai; T Ozawa; J Fujii; T Omae Journal: Hypertens Res Date: 2000-11 Impact factor: 3.872
Authors: J A Staessen; J Gasowski; J G Wang; L Thijs; E Den Hond; J P Boissel; J Coope; T Ekbom; F Gueyffier; L Liu; K Kerlikowske; S Pocock; R H Fagard Journal: Lancet Date: 2000-03-11 Impact factor: 79.321
Authors: B M Psaty; C D Furberg; L H Kuller; N O Borhani; P M Rautaharju; D H O'Leary; D E Bild; J Robbins; L P Fried; C Reid Journal: JAMA Date: 1992-09-09 Impact factor: 56.272
Authors: M B Mittelmark; B M Psaty; P M Rautaharju; L P Fried; N O Borhani; R P Tracy; J M Gardin; D H O'Leary Journal: Am J Epidemiol Date: 1993-02-01 Impact factor: 4.897
Authors: Jeff Whittle; Amy I Lynch; Rikki M Tanner; Lara M Simpson; Barry R Davis; Mahboob Rahman; Paul K Whelton; Suzanne Oparil; Paul Muntner Journal: Clin J Am Soc Nephrol Date: 2016-02-18 Impact factor: 8.237
Authors: Keith M Diaz; Rikki M Tanner; Louise Falzon; Emily B Levitan; Kristi Reynolds; Daichi Shimbo; Paul Muntner Journal: Hypertension Date: 2014-07-28 Impact factor: 10.190
Authors: Elaine Ku; Rebecca Scherzer; Michelle C Odden; Michael Shlipak; Carole L White; Thalia S Field; Oscar Benavente; Pablo E Pergola; Carmen A Peralta Journal: Blood Press Date: 2017-09-27 Impact factor: 2.835
Authors: Adam de Havenon; Nora F Fino; Brian Johnson; Ka-Ho Wong; Jennifer J Majersik; David Tirschwell; Natalia Rost Journal: Stroke Date: 2019-09-20 Impact factor: 7.914
Authors: Sophie E Claudel; Joel Adu-Brimpong; Alnesha Banks; Colby Ayers; Michelle A Albert; Sandeep R Das; James A de Lemos; Tammy Leonard; Ian J Neeland; Joshua P Rivers; Tiffany M Powell-Wiley Journal: Am Heart J Date: 2018-08-06 Impact factor: 4.749
Authors: Chenkai Wu; Michael G Shlipak; Robert S Stawski; Carmen A Peralta; Bruce M Psaty; Tamara B Harris; Suzanne Satterfield; Eric J Shiroma; Anne B Newman; Michelle C Odden Journal: Am J Hypertens Date: 2016-09-06 Impact factor: 2.689